NELFINAVIR for Chronic hepatitis c: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 9 adverse event reports in the FDA FAERS database where NELFINAVIR was used for Chronic hepatitis c.
Most Reported Side Effects for NELFINAVIR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Foetal exposure during pregnancy | 290 | 24.9% | 4 | 48 |
| Drug resistance | 117 | 10.1% | 10 | 7 |
| Lipodystrophy acquired | 112 | 9.6% | 1 | 1 |
| Virologic failure | 111 | 9.5% | 7 | 8 |
| Viral mutation identified | 104 | 8.9% | 2 | 0 |
| Eyelid ptosis | 88 | 7.6% | 0 | 0 |
| Pathogen resistance | 87 | 7.5% | 0 | 0 |
| Mitochondrial toxicity | 86 | 7.4% | 0 | 1 |
| Diplopia | 83 | 7.1% | 0 | 0 |
| Progressive external ophthalmoplegia | 73 | 6.3% | 0 | 0 |
| Treatment failure | 69 | 5.9% | 14 | 0 |
| Maternal exposure during pregnancy | 55 | 4.7% | 0 | 12 |
| Pregnancy | 49 | 4.2% | 2 | 7 |
| Premature baby | 48 | 4.1% | 1 | 13 |
| Treatment noncompliance | 48 | 4.1% | 1 | 7 |
Other Indications for NELFINAVIR
Hiv infection (708)
Product used for unknown indication (200)
Antiretroviral therapy (56)
Hiv test positive (18)
Prophylaxis against hiv infection (17)
Plasma cell myeloma (12)
Pancreatic carcinoma (11)
Perinatal hiv infection (11)
Acquired immunodeficiency syndrome (10)
Hepatitis c (10)
Other Drugs Used for Chronic hepatitis c
RIBAVIRIN (15,707)
PEGINTERFERON ALFA-2A (7,898)
LEDIPASVIR\SOFOSBUVIR (6,621)
SOFOSBUVIR\VELPATASVIR (6,405)
SOFOSBUVIR (6,008)
TELAPREVIR (3,103)
GLECAPREVIR\PIBRENTASVIR (3,072)
SIMEPREVIR (2,735)
DACLATASVIR (2,063)
PEGINTERFERON ALFA-2B (1,927)